Intellinetics, Inc. (INLX) AI Stock Analysis

NYSE American: INLXAI research summary: business, growth, valuation, analysts, bull and bear case.

INLX AI stock analysis summary

AI Research

Intellinetics, Inc. provides document management software and conversion services across healthcare, education, and government markets. The company delivered a 5-year revenue CAGR of 15.0% through FY2025, but sales declined 8.0% to $16.6M in FY2025 alongside a net loss of -$1.9M. For the trailing twelve months ended June 30, 2026, operating margin stood at -27.6% while revenue reached $16.2M.

Market cap
$21.0M
Revenue (TTM)
$16.2M
P/E
—
fwd 158.7x
1Y return
-57.8%
S&P 500 16.8%
Avg. target
$14.50
209.8% vs last close

Bull case

  • Gross margin improved consistently from 56.8% in FY2023 to 66.0% in FY2025.
  • Free cash flow remained positive in FY2025 at $579,493 despite the annual net loss.
  • The company holds net cash of $126,551 with total debt of $1.6M as of June 30, 2026.

Bear case

  • Annual revenue fell 8.0% in FY2025 to $16.6M, and quarterly revenue declined 1.6% in the quarter ended June 30, 2026.
  • Operating margin on a trailing twelve months basis was -27.6%, leading to a net margin of -17.6%.
  • The stock fell 57.8% over the past year and closed at $4.68, which is 28.7% below its 200-day average.

What Intellinetics does

Intellinetics, Inc. operates in the document services and software solutions market across two segments: Document Management and Document Conversion. The company designs, develops, tests, markets, and licenses software platforms that handle document capture and management across digital and physical formats, including paper scans, Microsoft Office 365 files, images, audio, video, and emails. Its IntelliCloud platform offers image processing, records management, and workflow solutions. In addition, Intellinetics provides installation, integration, training, consulting, and maintenance services, along with digital scanning, microfilm and microfiche services, physical box storage, and business process outsourcing for clients in healthcare, education, public safety, and government sectors.

Growth and profitability

Intellinetics expanded revenue from $11.5M in FY2021 to a peak of $18.0M in FY2024 before revenue declined 8.0% to $16.6M in FY2025. Gross margin expanded from 60.6% in FY2021 to 66.0% in FY2025. However, profitability deteriorated, with operating margin falling from 9.7% in FY2021 to -10.8% in FY2025, resulting in a net loss of -$1.9M and an eps of -$0.43. For the trailing twelve months ended June 30, 2026, revenue stood at $16.2M with a net profit margin of -17.6% and eps of -$0.64. In the latest quarter ended June 30, 2026, quarterly revenue fell 1.6% year-over-year, while quarterly earnings dropped 40.9%.

INLX income statement →

Balance sheet and cash flow

As of June 30, 2026, Intellinetics held cash and short-term investments of $1.7M against total debt of $1.6M, resulting in net cash of $126,551. Shareholders' equity was $9.8M, total assets stood at $15.6M, and the debt-to-equity ratio was 0.16. The current ratio was 0.75. In FY2025, the company generated $933,871 in operating cash flow and $579,493 in free cash flow, with capital expenditures of $354,378. Over a 5-year period, the share count increased 43.7%.

INLX balance sheet →

Valuation and performance

With a market cap of $21.0M and an enterprise value of $22.8M, INLX trades at an EV to EBITDA ratio of 24.3x, compared to 16.6x for the median of its US-listed Technology peers. Its forward PE ratio is 158.7x versus the peer median of 18.8x, while its price-to-sales multiple of 1.3x sits below the peer median of 2.8x. Over the past year, INLX shares fell 57.8%, lagging the S&P 500 return of 16.8%.

INLX key metrics →

What analysts expect

Intellinetics has 1 Buy rating and 0 ratings in Strong Buy, Hold, Sell, or Strong Sell categories. The mean price target is $14.50, representing an upside of 209.8% over the last close of $4.68 on October 16, 2026. The revenue estimate for the current fiscal year ending December 31, 2026, is $0. Intellinetics beat EPS estimates in each of the last 4 quarters, and its next earnings date is November 11, 2026.

INLX forecast and price target →

Key risks and what to watch

  • The current ratio stood at 0.75 as of June 30, 2026, indicating short-term liquidity constraints.
  • Shareholder dilution is a factor, with the share count increasing 43.7% over a 5-year span.
  • Return on equity over the trailing twelve months was -26.6%, highlighting ongoing operational losses.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this INLX AI stock analysis

This page is an AI-written research summary of Intellinetics, Inc. (INLX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: INLX income statement, INLX balance sheet, INLX key metrics, INLX analyst forecast, INLX chart. See the INLX stock overview for the latest quote and news.

INLX AI stock analysis FAQ

What is Intellinetics, Inc.'s stock ticker and primary exchange?

Intellinetics trades under the ticker symbol INLX on the NYSE American exchange.

Does Intellinetics pay a dividend?

No, Intellinetics does not currently pay a dividend to shareholders.

What was the revenue and net income for Intellinetics in FY2025?

For FY2025, Intellinetics recorded revenue of $16.6M and a net loss of -$1.9M, representing a net margin of -11.3%.

What is the consensus analyst price target for INLX?

The mean analyst price target is $14.50, which is 209.8% above its closing price of $4.68 on October 16, 2026.

More Technology AI stock analysis